.jpg)
Who Should Get Screened for Lung Cancer?
Lung cancer is associated with the following risk factors:
- Age 50 or above
- Family history of lung cancer
- Smoking or having quit smoking within the last 15 years
- Prolonged exposure to secondhand smoke
- Air pollution (indoor and outdoor)
- Occupational exposure (e.g. to radon or asbestos)
Multiple international studies and guidelines recommend that “high-risk individuals” undergo low-dose chest CT (LDCT) screening every 1–2 years:
- Aged 50 to 80
- Smoking index^ (pack-years) greater than 20
- Currently smoking or quit smoking within the last 15 years
^Smoking index = Number of cigarettes smoked per day (packs) x Years of smoking
However, increasing medical research has found that among Asian populations, non-smokers account for a significant proportion of all lung cancer cases, and their incidence rates may not differ significantly from those of smokers. Therefore, non-smokers are advised to consult a doctor for professional advice before considering lung cancer screening. |
Health Screening Plan
Lung Cancer Screening Plan
As the leading cause of cancer death in Hong Kong, lung cancer often shows no symptoms until late stage. Detection and treatment at early stage can greatly improve survival.
“High-risk individuals” undergoing lung cancer screening by low-dose CT scan of thorax can potentially reduce cancer-related mortality by up to 39%.
Screening package includes:
Consultation Provided by Specialist in Cardio-Thoracic Surgery
- Before Scan: Counseling relevant information of screening by specialist in Cardio-Thoracic Surgery
- Low-dose CT scan of Thorax (LDCT)
- After Scan: Follow-up plan by specialist in Cardio-Thoracic Surgery
The entire screening plan is HKD$1,980. Please contact us for more enquiries.
References:
- Centre For Health Protection - Lung Cancer from https://www.chp.gov.hk/en/healthtopics/content/25/49.html?fbclid=IwAR2rnLKFSaVEHvFPfSR4Ukhitixis-_jRGbX9MynYSBJy6xBiF66S-LdVU4
- Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117.
- Recommendations on Prevention and Screening for Lung Cancer For Health Professionals, Cancer Expert Working Group on Cancer Prevention and Screening (CEWG), The Centre for Health Protection, Department of Health, HKSAR
- Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, Colombet M, Bray F. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respir Med. 2025;13(4):348-363. doi: 10.1016/S2213-2600(24)00428-4.
- Li C, Cheng B, Li J, Xiong S, Fu W, Jiang Y, Zhou C, Zhong R, Li F, Zhang Q, Liang H, Wang W, Yang CJ, Potter AL, Du X, Qiu Q, Yang C, Sun B, Chen Y, Liu J, Xu B, Zhong N, Liang W, He J; LUNG-CARE Project. Non-Risk-Based Lung Cancer Screening With Low-Dose Computed Tomography. JAMA. 2025 21:e254017. doi: 10.1001/jama.2025.4017.